2014 Q1 Form 10-K Financial Statement
#000114420414015803 Filed on March 14, 2014
Income Statement
Concept | 2014 Q1 | 2013 Q4 | 2013 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $2.100M | $2.970M | $10.10M |
YoY Change | -15.32% | 10.82% | 16.49% |
% of Gross Profit | |||
Research & Development | $4.487M | $6.550M | $25.68M |
YoY Change | -24.89% | 16.55% | 47.02% |
% of Gross Profit | |||
Depreciation & Amortization | $5.000K | $10.00K | $17.00K |
YoY Change | 66.67% | 466.67% | |
% of Gross Profit | |||
Operating Expenses | $6.582M | $9.520M | $35.78M |
YoY Change | 10.18% | 14.7% | 104.83% |
Operating Profit | -$6.582M | -$9.524M | -$35.78M |
YoY Change | -22.18% | 14.76% | 31.66% |
Interest Expense | $966.0K | -$270.0K | $1.923M |
YoY Change | 102.94% | -27.03% | 187.01% |
% of Operating Profit | |||
Other Income/Expense, Net | -$788.0K | -$1.378M | |
YoY Change | |||
Pretax Income | -$7.370M | -$9.800M | -$37.16M |
YoY Change | -16.82% | 13.16% | 34.59% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$7.370M | -$9.798M | -$37.16M |
YoY Change | -16.8% | 13.09% | 34.58% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$205.3K | -$274.4K | -$1.221M |
COMMON SHARES | |||
Basic Shares Outstanding | 44.09M shares | 35.61M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2014 Q1 | 2013 Q4 | 2013 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $80.00M | $99.50M | $99.50M |
YoY Change | 81.41% | 147.51% | 147.51% |
Cash & Equivalents | $79.98M | $99.52M | $99.50M |
Short-Term Investments | |||
Other Short-Term Assets | $500.0K | $500.0K | $500.0K |
YoY Change | -50.0% | 25.0% | 25.0% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $80.50M | $100.0M | $100.0M |
YoY Change | 78.5% | 146.43% | 146.31% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $69.00K | $447.0K | $400.0K |
YoY Change | -31.0% | 776.47% | 300.0% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $250.0K | ||
YoY Change | |||
Other Assets | $70.00K | $104.0K | $100.0K |
YoY Change | -76.67% | -70.2% | -66.67% |
Total Long-Term Assets | $14.40M | $551.0K | $600.0K |
YoY Change | 3499.5% | 37.75% | 50.0% |
TOTAL ASSETS | |||
Total Short-Term Assets | $80.50M | $100.0M | $100.0M |
Total Long-Term Assets | $14.40M | $551.0K | $600.0K |
Total Assets | $94.90M | $100.6M | $100.6M |
YoY Change | 108.58% | 145.37% | 145.37% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $872.0K | $468.0K | $500.0K |
YoY Change | 24.57% | -54.52% | -50.0% |
Accrued Expenses | $3.438M | $4.430M | $4.500M |
YoY Change | 49.48% | 102.75% | 95.65% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | $6.200M | $6.200M |
YoY Change | -100.0% | 244.44% | 244.44% |
Total Short-Term Liabilities | $4.335M | $11.21M | $11.20M |
YoY Change | -30.08% | 118.43% | 119.61% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $14.00M | $7.000M | $7.000M |
YoY Change | 26.13% | -43.55% | -43.55% |
Other Long-Term Liabilities | $1.066M | $1.077M | $1.100M |
YoY Change | -28.93% | -25.26% | -21.43% |
Total Long-Term Liabilities | $1.066M | $1.077M | $8.100M |
YoY Change | -91.54% | -25.26% | -41.3% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.335M | $11.21M | $11.20M |
Total Long-Term Liabilities | $1.066M | $1.077M | $8.100M |
Total Liabilities | $19.41M | $19.30M | $19.30M |
YoY Change | 3.8% | 1.82% | 1.58% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$128.7M | -$121.3M | |
YoY Change | 44.14% | ||
Common Stock | $44.00K | $40.00K | |
YoY Change | 66.67% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $75.49M | $81.28M | $81.30M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $94.90M | $100.6M | $100.6M |
YoY Change | 108.57% | 145.37% | 145.37% |
Cashflow Statement
Concept | 2014 Q1 | 2013 Q4 | 2013 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$7.370M | -$9.798M | -$37.16M |
YoY Change | -16.8% | 13.09% | 34.58% |
Depreciation, Depletion And Amortization | $5.000K | $10.00K | $17.00K |
YoY Change | 66.67% | 466.67% | |
Cash From Operating Activities | -$6.070M | -$7.140M | -$29.65M |
YoY Change | -18.96% | 0.56% | 27.82% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $150.0K | $40.00K |
YoY Change | -400.0% | -25.93% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$250.0K | -$150.0K | -$150.0K |
YoY Change | -34.78% | -34.78% | |
Cash From Investing Activities | -$250.0K | $0.00 | -$188.0K |
YoY Change | -100.0% | -32.62% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $481.0K | $91.34M | |
YoY Change | -95.89% | 216.54% | |
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -13.22M | 390.0K | $89.16M |
YoY Change | -216.48% | 290.0% | 120.07% |
NET CHANGE | |||
Cash From Operating Activities | -6.070M | -7.140M | -$29.65M |
Cash From Investing Activities | -250.0K | 0.000 | -$188.0K |
Cash From Financing Activities | -13.22M | 390.0K | $89.16M |
Net Change In Cash | -19.54M | -6.750M | $59.32M |
YoY Change | -606.22% | -7.28% | 248.15% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$6.070M | -$7.140M | -$29.65M |
Capital Expenditures | $0.00 | $150.0K | $40.00K |
Free Cash Flow | -$6.070M | -$7.290M | -$29.69M |
YoY Change | -18.96% | 3.4% | 27.69% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt"></font></b> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <font style="FONT-SIZE: 10pt">The Company’s consolidated financial statements include certain amounts that are based on management’s best estimates and judgments. The Company’s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, the valuation of its common stock (“Common stock”) prior to the Company becoming public and Common stock warrants, stock options, accrued expenses, provisions for income taxes and contingencies. Due to the uncertainty inherent in such estimates, actual results may differ from our estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt">Concentration of Risk</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt"></font></b> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <font style="FONT-SIZE: 10pt">The Company is currently completely dependent on third party manufacturers for product supply. In particular, the Company currently relies exclusively on Ovamed GmbH (“Ovamed”) to supply it with its requirements of <i> Trichuris suis</i> ova (“TSO”). Ovamed is the sole supplier of this product, which it is currently producing at only one facility in Germany, where it is also producing product for third parties, including Dr. Falk Pharma GmbH (“Falk”). Ovamed also relies on certain other suppliers for materials and services. Similarly, the Company currently relies on BioReliance Corporation, Progenitor Cell Therapy LLC and other third parties for its CNDO–109 product requirements. The Company’s clinical development programs would be adversely affected by a significant interruption in obtaining clinical trial supplies.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
447000 | USD |
CY2012Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
12386000 | USD |
CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
18959000 | USD |
CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
393000 | USD |
CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
40592000 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
40199000 | USD |
CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
51000 | USD |
CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5090171 | shares |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
23160000 | USD |
CY2006Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2011 | us-gaap |
Interest Paid
InterestPaid
|
53000 | USD |
CY2012 | us-gaap |
Interest Paid
InterestPaid
|
421000 | USD |
CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
7017000 | USD |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
19304000 | USD |
CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11210000 | USD |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
40000 | USD |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
202580000 | USD |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-121342000 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
81278000 | USD |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
100582000 | USD |
CY2012 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
3638000 | USD |
CY2013 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
5902000 | USD |
us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
13414000 | USD | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.34 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.76 | |
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
641000 | USD | |
CY2013Q4 | cndo |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
1245000 | USD |
CY2012Q4 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
0 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
99521000 | USD |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
510000 | USD |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
100031000 | USD |
CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
349000 | USD |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
104000 | USD |
CY2012Q4 | us-gaap |
Assets
Assets
|
40992000 | USD |
CY2013Q4 | us-gaap |
Assets
Assets
|
100582000 | USD |
CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1029000 | USD |
CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
468000 | USD |
CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2185000 | USD |
CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4430000 | USD |
CY2012Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1799000 | USD |
CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
6203000 | USD |
CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5132000 | USD |
CY2012Q4 | cndo |
Other Long Term Liabilities
OtherLongTermLiabilities
|
1441000 | USD |
CY2013Q4 | cndo |
Other Long Term Liabilities
OtherLongTermLiabilities
|
1077000 | USD |
CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
24000 | USD |
CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
106193000 | USD |
CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-84184000 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22033000 | USD |
CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
40992000 | USD |
CY2013Q4 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
190000 | USD |
CY2012 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
3361 | shares |
CY2012Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
5750000 | shares |
CY2013Q4 | us-gaap |
Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
|
1 | pure |
CY2012Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
63000 | USD |
CY2013Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
43000 | USD |
CY2013 | cndo |
Percentage Of Tax Benefit Likely Of Being Realized
PercentageOfTaxBenefitLikelyOfBeingRealized
|
0.5 | pure |
CY2011 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-42221000 | USD |
CY2012 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-27610000 | USD |
CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-37158000 | USD |
CY2011 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7662984 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
21654984 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
30429743 | shares |
CY2011 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-5.51 | |
CY2011 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10206543 | shares |
CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3371161 | shares |
CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
54000 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
467000 | USD |
CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3000 | USD |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
20000 | USD |
CY2012Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
1064000 | USD |
CY2013Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
450000 | USD |
CY2012Q4 | us-gaap |
Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
|
354000 | USD |
CY2013Q4 | us-gaap |
Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
|
1502000 | USD |
CY2012Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
320000 | USD |
CY2013Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
351000 | USD |
CY2012Q4 | cndo |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
403000 | USD |
CY2012Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
44000 | USD |
CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
192000 | USD |
CY2012Q4 | cndo |
Notes Term Charges Payable
NotesTermChargesPayable
|
398000 | USD |
CY2013Q4 | cndo |
Notes Term Charges Payable
NotesTermChargesPayable
|
398000 | USD |
CY2012Q4 | cndo |
Other Long Term Liabilities Related To Manufacturing Rights
OtherLongTermLiabilitiesRelatedToManufacturingRights
|
1043000 | USD |
CY2013Q4 | cndo |
Other Long Term Liabilities Related To Manufacturing Rights
OtherLongTermLiabilitiesRelatedToManufacturingRights
|
679000 | USD |
CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1441000 | USD |
CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1077000 | USD |
CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
24400754 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39652950 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
24400754 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
39652950 | shares |
CY2011 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
1469000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2466590 | shares |
CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
-550157 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3117777 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3117777 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
2169444 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.31 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
4.31 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
3.75 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
0 | USD |
CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y6M14D | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y4M10D | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y4M10D | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P7Y10M13D | |
CY2011 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8583000 | USD |
CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
17468000 | USD |
CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
25682000 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
67691000 | USD | |
CY2011 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5755000 | USD |
CY2012 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8665000 | USD |
CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10098000 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
26377000 | USD | |
CY2011 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
20706000 | USD |
CY2012 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
1043000 | USD |
CY2013 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
0 | USD |
us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
21749000 | USD | |
CY2011 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-35044000 | USD |
CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27176000 | USD |
CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-35780000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-115817000 | USD | |
CY2011 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
165000 | USD |
CY2012 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
236000 | USD |
CY2013 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
545000 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1025000 | USD | |
CY2011 | us-gaap |
Interest Expense
InterestExpense
|
74000 | USD |
CY2012 | us-gaap |
Interest Expense
InterestExpense
|
670000 | USD |
CY2013 | us-gaap |
Interest Expense
InterestExpense
|
1923000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
5876000 | USD | |
CY2011 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
0 | USD |
CY2012 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
0 | USD |
CY2013 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
0 | USD |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
733000 | USD | |
CY2011 | cndo |
Warrant Expense
WarrantExpense
|
1407000 | USD |
CY2012 | cndo |
Warrant Expense
WarrantExpense
|
0 | USD |
CY2013 | cndo |
Warrant Expense
WarrantExpense
|
0 | USD |
cndo |
Warrant Expense
WarrantExpense
|
1407000 | USD | |
CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-36360000 | USD |
CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27610000 | USD |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37158000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-121342000 | USD | |
CY2011 | us-gaap |
Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
|
-5861000 | USD |
CY2012 | us-gaap |
Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
|
0 | USD |
CY2013 | us-gaap |
Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
|
0 | USD |
us-gaap |
Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
|
-5861000 | USD | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-127203000 | USD | |
CY2011 | cndo |
Noncash Interest
NoncashInterest
|
0 | USD |
CY2012 | cndo |
Noncash Interest
NoncashInterest
|
130000 | USD |
CY2013 | cndo |
Noncash Interest
NoncashInterest
|
536000 | USD |
cndo |
Noncash Interest
NoncashInterest
|
2434000 | USD | |
CY2011 | cndo |
Noncash Interest Related Parties
NoncashInterestRelatedParties
|
0 | USD |
CY2012 | cndo |
Noncash Interest Related Parties
NoncashInterestRelatedParties
|
0 | USD |
CY2013 | cndo |
Noncash Interest Related Parties
NoncashInterestRelatedParties
|
0 | USD |
cndo |
Noncash Interest Related Parties
NoncashInterestRelatedParties
|
286000 | USD | |
CY2011 | cndo |
Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
|
30000 | USD |
CY2012 | cndo |
Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
|
0 | USD |
CY2013 | cndo |
Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
|
0 | USD |
cndo |
Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
|
130000 | USD | |
CY2011 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
CY2012 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
CY2013 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
121000 | USD | |
CY2011 | cndo |
Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
|
0 | USD |
CY2012 | cndo |
Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
|
0 | USD |
CY2013 | cndo |
Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
|
0 | USD |
cndo |
Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
|
-234000 | USD | |
CY2011 | cndo |
Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
|
0 | USD |
CY2012 | cndo |
Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
|
0 | USD |
CY2013 | cndo |
Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
|
0 | USD |
cndo |
Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
|
831000 | USD | |
CY2011 | cndo |
Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
|
-1407000 | USD |
CY2012 | cndo |
Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
|
0 | USD |
CY2013 | cndo |
Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
|
0 | USD |
cndo |
Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
|
-1407000 | USD | |
CY2011 | us-gaap |
Depreciation
Depreciation
|
22000 | USD |
CY2012 | us-gaap |
Depreciation
Depreciation
|
3000 | USD |
CY2013 | us-gaap |
Depreciation
Depreciation
|
17000 | USD |
us-gaap |
Depreciation
Depreciation
|
61000 | USD | |
CY2011 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
160000 | USD |
CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
238000 | USD |
CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
117000 | USD |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
570000 | USD | |
CY2011 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1915000 | USD |
CY2012 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-260000 | USD |
CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1184000 | USD |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
4398000 | USD | |
CY2011 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10952000 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-23194000 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-29646000 | USD |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-76738000 | USD | |
CY2011 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
54000 | USD |
CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
40000 | USD |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
135000 | USD | |
CY2011 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
3843000 | USD |
CY2012 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
0 | USD |
CY2013 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
0 | USD |
us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
3843000 | USD | |
CY2011 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3843000 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-279000 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-188000 | USD |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4351000 | USD | |
CY2011 | cndo |
Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
|
0 | USD |
CY2012 | cndo |
Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
|
0 | USD |
CY2013 | cndo |
Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
|
0 | USD |
cndo |
Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
|
570000 | USD | |
CY2011 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
15000000 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
15000000 | USD | |
CY2011 | cndo |
Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
|
0 | USD |
CY2012 | cndo |
Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
|
0 | USD |
CY2013 | cndo |
Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
|
0 | USD |
cndo |
Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
|
570000 | USD | |
CY2011 | cndo |
Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
|
0 | USD |
CY2012 | cndo |
Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
|
750000 | USD |
CY2013 | cndo |
Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
|
0 | USD |
cndo |
Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
|
750000 | USD | |
CY2011 | cndo |
Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
|
0 | USD |
CY2012 | cndo |
Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
|
0 | USD |
CY2013 | cndo |
Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
|
0 | USD |
cndo |
Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
|
2221000 | USD | |
CY2011 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
25784000 | USD |
CY2012 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
0 | USD |
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
25784000 | USD | |
CY2011 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
0 | USD |
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
80000 | USD | |
CY2011 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
0 | USD |
CY2012 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
0 | USD |
CY2013 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
0 | USD |
us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
80000 | USD | |
CY2011 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
7570000 | USD | |
CY2011 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
CY2012 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
CY2013 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
737000 | USD | |
CY2011 | us-gaap |
Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
|
0 | USD |
CY2013 | us-gaap |
Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
|
0 | USD |
us-gaap |
Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
|
-600000 | USD | |
CY2011 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
193000 | USD |
CY2012 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
28855000 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
92399000 | USD |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
121452000 | USD | |
CY2011 | cndo |
Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
|
0 | USD |
CY2012 | cndo |
Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
|
2305000 | USD |
CY2013 | cndo |
Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
|
1898000 | USD |
cndo |
Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
|
4203000 | USD | |
CY2011 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
23093000 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
40512000 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
89156000 | USD |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
180610000 | USD | |
CY2011 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
8298000 | USD |
CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
17039000 | USD |
CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
59322000 | USD |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
99521000 | USD | |
CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14862000 | USD |
CY2013 | us-gaap |
Interest Paid
InterestPaid
|
1387000 | USD |
us-gaap |
Interest Paid
InterestPaid
|
1949000 | USD | |
CY2011 | cndo |
Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
|
750000 | USD |
CY2012 | cndo |
Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
|
0 | USD |
CY2013 | cndo |
Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
|
0 | USD |
cndo |
Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
|
750000 | USD | |
CY2013 | dei |
Document Type
DocumentType
|
10-K | |
CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2013 | dei |
Trading Symbol
TradingSymbol
|
CNDO | |
CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
44086387 | shares |
CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
CORONADO BIOSCIENCES INC | |
CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001429260 | |
CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
162039807 | USD |
CY2011 | cndo |
Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
|
-19000 | USD |
CY2012 | cndo |
Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
|
19000 | USD |
CY2013 | cndo |
Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
|
0 | USD |
cndo |
Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
|
0 | USD | |
CY2011 | cndo |
Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
|
0 | USD |
CY2012 | cndo |
Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
|
225000 | USD |
CY2013 | cndo |
Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
|
148000 | USD |
cndo |
Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
|
373000 | USD | |
CY2011 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
119000 | USD |
CY2013 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-10000 | USD |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
109000 | USD | |
CY2012Q4 | cndo |
Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
|
30000000 | USD |
CY2012Q3 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
14700000 | USD |
CY2012Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
15000000 | USD |
CY2013 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
373000 | USD |
CY2011 | cndo |
Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
|
0 | USD |
CY2012 | cndo |
Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
|
0 | USD |
CY2013 | cndo |
Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
|
1345000 | USD |
cndo |
Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
|
1345000 | USD | |
CY2011 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | USD |
CY2012 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
288000 | USD |
CY2013 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | USD |
us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
288000 | USD | |
CY2012Q4 | cndo |
Other Short Term Liabilities Related To Manufacturing Rights
OtherShortTermLiabilitiesRelatedToManufacturingRights
|
0 | USD |
CY2013Q4 | cndo |
Other Short Term Liabilities Related To Manufacturing Rights
OtherShortTermLiabilitiesRelatedToManufacturingRights
|
500000 | USD |
CY2013 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.04 | pure |
CY2012 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
85000 | USD |
CY2013 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
107000 | USD |
CY2012Q4 | cndo |
Related Party Other Investment Percentage In Entity By Principal Stockholder Or Director
RelatedPartyOtherInvestmentPercentageInEntityByPrincipalStockholderOrDirector
|
0.141 | pure |
CY2013Q4 | cndo |
Related Party Other Investment Percentage In Entity By Principal Stockholder Or Director
RelatedPartyOtherInvestmentPercentageInEntityByPrincipalStockholderOrDirector
|
0.141 | pure |
CY2014Q1 | cndo |
Related Party Other Investment Percentage In Entity By Familys Of Principal Stockholder Or Director
RelatedPartyOtherInvestmentPercentageInEntityByFamilysOfPrincipalStockholderOrDirector
|
0.150 | pure |
CY2013 | cndo |
Underwriting Commission Incurred
UnderwritingCommissionIncurred
|
187000 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
351000 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
365000 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
291000 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
202000 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
22000 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1231000 | USD |
CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6581000 | USD |
CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8458000 | USD |
CY2012Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6465000 | USD |
CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10294000 | USD |
CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5831000 | USD |
CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7504000 | USD |
CY2012Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8299000 | USD |
CY2013Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9524000 | USD |
CY2012Q1 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
25000 | USD |
CY2013Q1 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-400000 | USD |
CY2012Q2 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
10000 | USD |
CY2013Q2 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-376000 | USD |
CY2012Q3 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-104000 | USD |
CY2013Q3 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-328000 | USD |
CY2012Q4 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-365000 | USD |
CY2013Q4 | cndo |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-274000 | USD |
CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6556000 | USD |
CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8858000 | USD |
CY2012Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6455000 | USD |
CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10670000 | USD |
CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5935000 | USD |
CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7832000 | USD |
CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8664000 | USD |
CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9798000 | USD |
CY2012Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.35 | |
CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.35 | |
CY2012Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.34 | |
CY2013Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.38 | |
CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.24 | |
CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.24 | |
CY2012Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.36 | |
CY2013Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.27 | |
CY2011 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
165000 | USD |
CY2012 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
93000 | USD |
CY2013 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
284000 | USD |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
|
One-third of the shares underlying the option were to vest on December 28, 2013 and each annual anniversary thereafter, subject to Dr. Weisman’s continued employment with the Company. | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
19572 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
31450 | USD |
CY2011 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
0 | USD |
CY2012 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
609000 | USD |
CY2013 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
1903000 | USD |
us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
3544000 | USD | |
CY2011 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
74000 | USD |
CY2012 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
55000 | USD |
CY2013 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
503000 | USD | |
CY2012Q4 | cndo |
Deferred Tax Assets Amortization Of Upfront Fees
DeferredTaxAssetsAmortizationOfUpfrontFees
|
3087 | USD |
CY2013Q4 | cndo |
Deferred Tax Assets Amortization Of Upfront Fees
DeferredTaxAssetsAmortizationOfUpfrontFees
|
2865 | USD |
CY2011 | cndo |
Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
|
0 | USD |
CY2012 | cndo |
Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
|
0 | USD |
CY2013 | cndo |
Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
|
0 | USD |
cndo |
Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
|
831000 | USD | |
CY2011 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
0 | USD |
CY2012 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
6000 | USD |
CY2013 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
20000 | USD |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
764000 | USD | |
CY2012Q4 | cndo |
Deferred Tax Assets Amortization Of In Process Research And Development
DeferredTaxAssetsAmortizationOfInProcessResearchAndDevelopment
|
407 | USD |
CY2013Q4 | cndo |
Deferred Tax Assets Amortization Of In Process Research And Development
DeferredTaxAssetsAmortizationOfInProcessResearchAndDevelopment
|
460 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
1522 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
2827 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
622 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
854 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
991 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
2686 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
26201 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
41142 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
26201 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
41142 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.05 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.04 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.04 | pure |
CY2011 | cndo |
Effective Income Tax Rate Reconciliation Acquired Net Operating Losses Nol
EffectiveIncomeTaxRateReconciliationAcquiredNetOperatingLossesNol
|
0.09 | pure |
CY2012 | cndo |
Effective Income Tax Rate Reconciliation Acquired Net Operating Losses Nol
EffectiveIncomeTaxRateReconciliationAcquiredNetOperatingLossesNol
|
0 | pure |
CY2013 | cndo |
Effective Income Tax Rate Reconciliation Acquired Net Operating Losses Nol
EffectiveIncomeTaxRateReconciliationAcquiredNetOperatingLossesNol
|
0 | pure |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.02 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.01 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.04 | pure |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.21 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.02 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.02 | pure |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.02 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.05 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.01 | pure |
CY2011 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2011Q4 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
11496186 | shares |
CY2007Q2 | cndo |
Stock Issued To Founders Shares
StockIssuedToFoundersShares
|
2125096 | shares |
CY2007Q2 | cndo |
Stock Issued To Founders Par Value
StockIssuedToFoundersParValue
|
0.001 | |
CY2013Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2009 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
|
5000 | shares |
CY2010 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
|
23836 | shares |
CY2010 | cndo |
Share Based Goods And Nonemployee Services Transaction Fair Value Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionFairValueOfSecuritiesIssued
|
82000 | USD |
CY2011 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
193000 | USD |
CY2011Q2 | cndo |
Issuance Of Common Stock Special Dividend To Series Convertible Preferred Stock Shares
IssuanceOfCommonStockSpecialDividendToSeriesConvertiblePreferredStockShares
|
2178917 | shares |
CY2013 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
10558422 | shares |
CY2012Q2 | cndo |
Stock Issued During Period Shares For Over Allotment Option Exercised By Underwriter
StockIssuedDuringPeriodSharesForOverAllotmentOptionExercisedByUnderwriter
|
750000 | shares |
CY2012Q2 | cndo |
Stock Issued During Period New Issues Price Per Share
StockIssuedDuringPeriodNewIssuesPricePerShare
|
5.00 | |
CY2011 | cndo |
Effective Incometax Rate Reconciliation Prior Year State Net Operating Loss True Up
EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp
|
0.01 | pure |
CY2012 | cndo |
Effective Incometax Rate Reconciliation Prior Year State Net Operating Loss True Up
EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp
|
0.02 | pure |
CY2012 | cndo |
Effective Income Tax Rate Reconciliation Prior Year Federa Net Operating Loss True Up
EffectiveIncomeTaxRateReconciliationPriorYearFederaNetOperatingLossTrueUp
|
0.03 | pure |
CY2013 | cndo |
Effective Income Tax Rate Reconciliation Prior Year Federa Net Operating Loss True Up
EffectiveIncomeTaxRateReconciliationPriorYearFederaNetOperatingLossTrueUp
|
0.01 | pure |
CY2012Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
26400000 | USD |
CY2011 | cndo |
Effective Income Tax Rate Reconciliation State Rate Change
EffectiveIncomeTaxRateReconciliationStateRateChange
|
0.03 | pure |
CY2010 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
700000 | USD |
CY2012Q4 | cndo |
Error Related To Taxation Overstatement Of Gross Deferred Tax Asset Amount
ErrorRelatedToTaxationOverstatementOfGrossDeferredTaxAssetAmount
|
3600000 | USD |
CY2012Q4 | cndo |
Error Related To Taxation Understatement Of Valuation Amount
ErrorRelatedToTaxationUnderstatementOfValuationAmount
|
3600000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
6203000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
6866000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
587000 | USD |
CY2012 | cndo |
Tax Payer Relief Act Research Credit Extension Period
TaxPayerReliefActResearchCreditExtensionPeriod
|
P2Y | |
CY2012Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
5.72 | |
CY2012Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
20000 | shares |
CY2012Q3 | cndo |
Class Of Warrant Or Right Fair Value Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightFairValueOfSecuritiesCalledByWarrantsOrRights
|
92000 | USD |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2519070 | shares |
CY2012Q3 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
1.0451 | pure |
CY2012Q3 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.0106 | pure |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.37 | |
CY2012Q3 | us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2012Q3 | us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P6Y | |
CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
329000 | USD |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
2860000 | USD |
CY2010Q3 | cndo |
Repayment Premium Senior Convertible Notes
RepaymentPremiumSeniorConvertibleNotes
|
0.429 | pure |
CY2011Q1 | us-gaap |
Repayments Of Assumed Debt
RepaymentsOfAssumedDebt
|
400000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
|
7303280 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
996720 | shares |
CY2013 | cndo |
Share Based Compensation Arrangement By Share Based Payment Award Contractual Term Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermOfAward
|
P10Y | |
CY2013Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
3400000 | USD |
CY2013 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y3M18D | |
CY2011Q4 | cndo |
Employee Stock Purchase Plan Authorized Number Of Shares
EmployeeStockPurchasePlanAuthorizedNumberOfShares
|
200000 | shares |
CY2013Q4 | cndo |
Employee Stock Purchase Plan Authorized Number Of Shares
EmployeeStockPurchasePlanAuthorizedNumberOfShares
|
200000 | shares |
CY2013Q4 | cndo |
Employee Stock Purchase Plan Offering Fair Value Reckoning Percentage
EmployeeStockPurchasePlanOfferingFairValueReckoningPercentage
|
0.85 | pure |
CY2011Q4 | cndo |
Employee Stock Purchase Plan Offering Fair Value Reckoning Percentage
EmployeeStockPurchasePlanOfferingFairValueReckoningPercentage
|
0.85 | pure |
CY2013Q4 | cndo |
Employee Stock Purchase Plan Offering Fair Value Reckoning Percentage
EmployeeStockPurchasePlanOfferingFairValueReckoningPercentage
|
0.85 | pure |
CY2013Q4 | cndo |
Employee Stock Purchase Plan Number Of Shares Purchased By Employees
EmployeeStockPurchasePlanNumberOfSharesPurchasedByEmployees
|
49214 | shares |
CY2012Q4 | cndo |
Employee Stock Purchase Plan Number Of Shares Available For Future Sale
EmployeeStockPurchasePlanNumberOfSharesAvailableForFutureSale
|
95000 | shares |
CY2013Q4 | cndo |
Employee Stock Purchase Plan Number Of Shares Available For Future Sale
EmployeeStockPurchasePlanNumberOfSharesAvailableForFutureSale
|
46000 | shares |
CY2012 | cndo |
Employee Stock Purchase Plan Compensation Expense Recognized
EmployeeStockPurchasePlanCompensationExpenseRecognized
|
95000 | USD |
CY2013 | cndo |
Employee Stock Purchase Plan Compensation Expense Recognized
EmployeeStockPurchasePlanCompensationExpenseRecognized
|
46000 | USD |
CY2007 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2644000 | USD |
CY2008 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3799000 | USD |
CY2009 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3666000 | USD |
CY2010 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9982000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-123000 | USD | |
CY2007 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2000 | USD |
CY2007 | cndo |
Issuance Of Restricted Common Stock To Non Employees
IssuanceOfRestrictedCommonStockToNonEmployees
|
2000 | USD |
CY2007 | cndo |
Issuance Of Restricted Common Stock To Employees
IssuanceOfRestrictedCommonStockToEmployees
|
1000 | USD |
CY2013 | cndo |
Issuance Of Restricted Common Stock To Employees
IssuanceOfRestrictedCommonStockToEmployees
|
0 | USD |
CY2007 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
13000 | USD |
CY2008 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
25000 | USD |
CY2009 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
39000 | USD |
CY2010 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
2329000 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
1469000 | USD |
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
3961000 | USD |
CY2013Q3 | cndo |
Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
|
200000000 | USD |
CY2012Q3 | cndo |
Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
|
75000000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
-1317726 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.51 | |
CY2008Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000 | USD |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19132000 | USD |
CY2006Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-123000 | USD |
CY2008Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
4762266 | shares |
CY2013 | cndo |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
1000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
5902000 | USD |
CY2008 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
20000 | USD |
CY2009 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
40000 | USD |
CY2010 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
40000 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
30000 | USD |
CY2010 | cndo |
Issuance Of Convertible Preferred Stock Upon Conversion Of Debt And Accrued Interest
IssuanceOfConvertiblePreferredStockUponConversionOfDebtAndAccruedInterest
|
0 | USD |
CY2010 | cndo |
Costs Related To Issuance Of Preferred Stock Series Including Common Stock Warrants
CostsRelatedToIssuanceOfPreferredStockSeriesIncludingCommonStockWarrants
|
621000 | USD |
CY2010 | cndo |
Reclassification Of Warrant Liability At Fair Value
ReclassificationOfWarrantLiabilityAtFairValue
|
234000 | USD |
CY2010 | cndo |
Change In Fair Value Of Embedded Conversion Feature Related To Related Party Notes And Senior Convertible Notes
ChangeInFairValueOfEmbeddedConversionFeatureRelatedToRelatedPartyNotesAndSeniorConvertibleNotes
|
831000 | USD |
CY2010 | cndo |
Issuance Of Common Stock To Non Employees For Services
IssuanceOfCommonStockToNonEmployeesForServices
|
82000 | USD |
CY2011 | cndo |
Issuance Of Common Stock Dividend To Preferred Stock
IssuanceOfCommonStockDividendToPreferredStock
|
0 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
193000 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
970000 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2693000 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
|
28750000 | USD |
CY2012 | cndo |
Stock Issuance Cost
StockIssuanceCost
|
2305000 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
87000 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
92000 | USD |
CY2012 | cndo |
Stock Issued During Period Shares Issued For Cash At Market Cost Value
StockIssuedDuringPeriodSharesIssuedForCashAtMarketCostValue
|
19000 | USD |
CY2013 | cndo |
Stock Issued During Period Shares Issued For Cash At Market Cost Value
StockIssuedDuringPeriodSharesIssuedForCashAtMarketCostValue
|
91337000 | USD |
CY2010 | cndo |
Issuance Of Common Stock Warrants To Non Employees For Services
IssuanceOfCommonStockWarrantsToNonEmployeesForServices
|
38000 | USD |
CY2009Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-15897000 | USD |
CY2006Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2007Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2749000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
66000 | USD |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
2200000 | USD | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
3.77 | USD |
CY2013Q4 | cndo |
Common Stock Offering Price
CommonStockOfferingPrice
|
70000000 | USD |
CY2013Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
478000 | USD |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.28 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.33 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.4 | pure |
CY2011 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
4000 | USD |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
4000 | USD | |
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
-1000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
-1899000 | USD |
CY2013Q2 | cndo |
Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
|
45000000 | USD |